copyright 1 MG-SEMAGLUTIDE for Dummies
The trial realized the two its Most important endpoints, with semaglutide 2.4 mg demonstrating statistically major and remarkable improvements in liver fibrosis without worsening of steatohepatitis, and resolution of steatohepatitis without worsening of liver fibrosis in people with MASH in comparison to placebo.1Your doctor will likely pause your